The mechanism of gap repair in yeast in the basis for development of a facile method for in vivo cloning of large fragments of genomic DNA. A yeast-bacteria shuttle vector, pCLASPER, linearized to expose interchangeable site-specific recombinogenic ends, can target homologous sequences in co-transformed genomic DNA. The genomic region delimited by the recombinogenic ends is recovered in pCLASPER via the high frequency of yeast homologous recombination. Recombinants are identified by acquisition of a yeast selectable marker. The cloned products can be transferred to E. Coli for large-scale growth and plasmid DNA extraction by standard alkaline lysis methods. Methods will be devised and adapted for optimal co-transformation efficiency of linearized vector and uncloned genomic DNA in S. cerevisiae, the length of homology necessary for target-specific cloning will be deytermined, and sources for generating targeting sequence will be tested. Targeted in vivo cloning provides a method for selective recovery of a single, specific genomic fragment from one or many individuals of a population, without library construction and of a size larger than amplified by long-range PCR. Applications include sequence gap closure , mapping and subcloning, haplotyping, population sampling mutational analysis, gene funtion, and phylogientic comparisons.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43HD035417-01
Application #
2026724
Study Section
Special Emphasis Panel (ZRG2-SSS-Y (14))
Project Start
1997-07-01
Project End
1997-12-31
Budget Start
1997-07-01
Budget End
1997-12-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Genaissance Pharmaceuticals, Inc.
Department
Type
DUNS #
City
New Haven
State
CT
Country
United States
Zip Code
06511